Second-Generation Long-Acting Injectable Antipsychotics and the Risk of Treatment Failure in a Population-Based Cohort

Second-Generation Long-Acting Injectable Antipsychotics and the Risk of Treatment Failure in a Population-Based Cohort

Introduction: Second-generation long-acting injectable antipsychotics (SG-LAIAs) may improve outcomes compared to other antipsychotics. Real-world studies using linked administrative databases play an important role in assessing the comparative effectiveness of antipsychotic medications.Methods: We...

Full description

Bibliographic Details
Main Authors: Donica Janzen, James M. Bolton, Christine Leong, I fan Kuo, Silvia Alessi-Severini
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Pharmacology
Subjects:
antipsychotic treatment
long-acting injectable and oral antipsychotics
real-world data
comparative effectiveness
psychotic disorders
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.879224/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.879224/full

Similar Items